Sandisk (SNDK)
NASDAQInformation TechnologyComputer HardwareSnapshot 2026-07-07
$1617.70-7.26%
Close 2026-07-07 · 1-day change
Reading SNDK? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track SNDK free→NASDAQInformation TechnologyComputer HardwareSnapshot 2026-07-07
Reading SNDK? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track SNDK free→QuarterlyIQ Insights · SNDK
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 10 valuation methods, at three horizons. Current price $1617.70. As of 2026-07-08. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 10% on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $1,618 SNDK trades at 52× p/e, in line with its 43× p/e peer median — but our blended $1,050 fair value sits well below the price. It's a high-confidence read. Analysts target $975–$3,000. Not investment advice.
$975.00 – $3000.00 (median $1400.00) · 23 analysts · as of 2026-06-29
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Flags: expensive valuation, weak execution quality. Capped at elevated by the Mania regime.
For similar setups historically (n=2,301): about 43% saw a 20%+ drawdown, and roughly 77% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Looks more expensive than peers.
Cheaper than its own typical valuation.
Trailing four: 2025-Q3, 2026-Q1, 2026-Q2, 2026-Q3
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $1400.00 | — | — | Analyst | high |
| dcf fcfe | 12M | $246.63 | — | — | Hist. CAGR | high |
| dcf fcff | 12M | $270.42 | — | — | Hist. CAGR | high |
| graham number | 12M | $247.88 | — | — | TTM | high |
| Peer EV/EBITDA | 12M | $517.01 | 21.4 | 23.06 | TTM | high |
| Peer P/FCF | 12M | $614.93 | 21.6 | 28.41 | TTM | high |
| Peer P/E | 12M | $1338.64 | 43.0 | 31.12 | TTM | high |
| Peer P/S | 12M | $405.57 | 4.8 | 83.97 | TTM | high |
| Own P/E history | 12M | $1914.46 | 61.5 | 31.12 | TTM | high |
| triangulated | 12M | $1518.15 | 43.0 | 35.29 | Triangulated | high |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.